Isoforms S and L of MRPL33 from alternative splicing have isoform‑specific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K/AKT signaling pathway-Reference-Cited by-同舟云学术

Isoforms S and L of MRPL33 from alternative splicing have isoform‑specific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K/AKT signaling pathway

Published:2019-02-27 Issue: Volume: Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Li Jie¹,Feng Dan¹,Gao Cuixia²,Zhang Yingyi¹,Xu Jing¹,Wu Meihong¹,Zhan Xianbao¹

Affiliation:

1. Department of Oncology, The Changhai Hospital, Shanghai 200433, P.R. China

2. Department of Research and Development, The Shanghai Polaris Biology Technology, Shanghai 201203, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the role of mitochondrial proteins SIRT5 and MRPL33 through Mendelian randomization in primary biliary cholangitis;Clinics and Research in Hepatology and Gastroenterology;2024-08

2. Alternative Splicing Factor Heterogeneous Nuclear Ribonucleoprotein U as a Promising Biomarker for Gastric Cancer Risk and Prognosis with Tumor-Promoting Properties;The American Journal of Pathology;2024-01

3. Assessing the causal relationship between mitochondria-associated proteins and chronic liver diseases：a comprehensive Mendelian randomisation study;2023-11-28

4. Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma;Clinical and Translational Radiation Oncology;2023-11

5. Elastic modulus-reflected liver lesion stiffness relates to worse prognosis in pancreatic cancer patients with liver metastasis;World Journal of Surgical Oncology;2023-08-24